NCT04524026 - RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions

IVF

Interventions

DRUG

Letrozole 5 mg

recFSH and co-treatment with letrozole 5 mg/day from stimulation day 1 on cycle day 2 or 3 until the day before GnRH agonist administration to trigger final oocyte maturation. GnRH antagonist 0.25 mg/day from stimulation day 5 until day of GnRH agonist administration. No luteal phase support.

Trial Locations (2)

2730

Herlev Hospitals Fertilitetsklinik, Herlev

4600

Sjællands Fertilitetsklinik, Køge